The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Refractory Idiopathic Urge Urinary Incontinence and Botulinum A Injection
Open accessAbstract
PURPOSE: We compared 200 U intradetrusor botulinum toxin A vs placebo in women with refractory idiopathic urge incontinence. MATERIALS AND METHODS: This institutional review board approved, multicenter registered trial randomized women with refractory urge incontinence, detrusor overactivity incontinence and 6 or greater urge incontinence episodes in 3 days to botulinum toxin A or placebo at a 2:1 ratio. Refractory was defined as inadequate symptom control after 2 or more attempts at pharmacotherapy and 1 or more other first line therapies for detrusor overactivity incontinence. The primary outcome measure was time to failure, as evidenced by a Patient Global Impression of Improvement score of 4 or greater at least 2 months after injection, or changes in treatment (initiation or increase) at any time after injection. Safety data, including increased post-void residual volume, defined as more than 200 ml irrespective of symptoms, was obtained at specified time points. RESULTS: Approximately 60% of the women who received botulinum toxin A had a clinical response based on the Patient Global Impression of Improvement. The median duration of their responses was 373 days, significantly longer than the 62 days or less for placebo (p <0.0001). In the botulinum toxin A group increased post-void residual urine (12 of 28 women or 43%) and urinary tract infection in those with increased post-void residual urine (9 of 12 or 75%) exceeded expected ranges. Further injections were stopped after 43 patients were randomized, including 28 to botulinum toxin A and 15 to placebo. CONCLUSIONS: Local injection of 200 U botulinum toxin A was an effective and durable treatment for refractory overactive bladder. However, a transient post-void residual urine increase was experienced in 43% of patients. Botulinum toxin A for idiopathic overactive bladder is still under investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Scheier, M. F., Carver, C. S., & Bridges, M. W. (1994) · Journal of Personality and Social Psychology · doi:10.1037//0022-3514.67.6.1063 · Cited by 7,456
SCHURCH, B., STÖHRER, M., KRAMER, G., SCHMID, D. M., GAUL, G., & HAURI, D. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67283-7 · Cited by 822
Barber, M. D., Kuchibhatla, M. N., Pieper, C. F., & Bump, R. C. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.118659 · Cited by 618
Self-citationApostolidis, A., Dasgupta, P., & Fowler, C. J. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.010 · Cited by 347
Rogers, R. G., Kammerer-Doak, D., Villarreal, A., Coates, K., & Qualls, C. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.111100 · Cited by 332
Sahai, A., Khan, M. S., Dasgupta, P., & GKT Botulinum Study Group (2007) · Journal of Urology · doi:10.1016/j.juro.2007.01.130 · Cited by 312
Giannantoni, A., Stasi, S. M. D., Stephen, R. L., Bini, V., Costantini, E., & Porena, M. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000132152.53532.5d · Cited by 154
Patel, A. K., Patterson, J. M., & Chapple, C. R. (2006) · European Urology · doi:10.1016/j.eururo.2006.07.022 · Cited by 114
Cited by
Gormley, E. A., Lightner, D. J., Faraday, M., & Vasavada, S. P. (2015) · Journal of Urology · doi:10.1016/j.juro.2015.01.087 · Cited by 789
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline
Gormley, E. A., Lightner, D. J., Burgio, K. L., Chai, T. C., Clemens, J. Q., Culkin, D. J., Das, A. K., Foster, H. E., Scarpero, H. M., Tessier, C. D., et al. (2012) · Journal of Urology · doi:10.1016/j.juro.2012.09.079 · Cited by 710
Nitti, V. W., Dmochowski, R., Herschorn, S., Sand, P., Thompson, C., Nardo, C., Yan, X., Haag-Molkenteller, C., & EMBARK Study Group (2013) · Journal of Urology · doi:10.1016/j.juro.2012.12.022 · Cited by 413
Dmochowski, R., Chapple, C., Nitti, V. W., Chancellor, M., Everaert, K., Thompson, C., Daniell, G., Zhou, J., & Haag-Molkenteller, C. (2010) · Journal of Urology · doi:10.1016/j.juro.2010.08.021 · Cited by 406
Nitti, V. W., Dmochowski, R., Herschorn, S., Sand, P., Thompson, C., Nardo, C., Yan, X., Haag-Molkenteller, C., & EMBARK Study Group S0022534716316627-20351d5d064fd7a57fb97540a9795212 C. Andreou, S.-1. R. B. E. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.109 · Cited by 330
Metadata
- Authors
- Brubaker, L., Richter, H. E., Visco, A., Mahajan, S., Nygaard, I., Braun, T. M., Barber, M. D., Menefee, S., Schaffer, J., Weber, A. M., Wei, J., & Pelvic Floor Disorders Network
- Venue
- Journal of Urology
- Published
- 2008-07
- Volume
- 180
- Issue
- 1
- Pages
- 217-222
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2141005094
- Cited by
- 328
- References
- 10
- FWCI
- 29.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.